These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28521841)

  • 1. TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
    Gudbrandsson B; Molberg Ø; Palm Ø
    Arthritis Res Ther; 2017 May; 19(1):99. PubMed ID: 28521841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
    Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
    Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
    Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
    Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
    Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Takayasu arteritis.
    Misra DP; Singh K; Rathore U; Kavadichanda CG; Ora M; Jain N; Agarwal V
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101826. PubMed ID: 37246052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances.
    Dammacco F; Cirulli A; Simeone A; Leone P; Pulli R; Angiletta D; Rubini G; Di Palo A; Vacca A; Dammacco R
    Clin Exp Med; 2021 Feb; 21(1):49-62. PubMed ID: 33026580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood Takayasu arteritis: disease course and response to therapy.
    Aeschlimann FA; Eng SWM; Sheikh S; Laxer RM; Hebert D; Noone D; Twilt M; Pagnoux C; Benseler SM; Yeung RSM
    Arthritis Res Ther; 2017 Nov; 19(1):255. PubMed ID: 29166923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
    Sahin S; Hopurcuoglu D; Bektas S; Belhan E; Adrovic A; Barut K; Canpolat N; Caliskan S; Sever L; Kasapcopur O
    Int J Rheum Dis; 2019 Jan; 22(1):132-139. PubMed ID: 30397997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile Takayasu: clinical features and long-term outcome.
    Miller-Barmak A; Sztajnbok F; Balik Z; Borzutzky A; Fogel LA; Goldzweig O; Ozen S; Butbul Aviel Y
    Rheumatology (Oxford); 2023 Sep; 62(9):3126-3132. PubMed ID: 36495199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis.
    Misra DP; Singh K; Rathore U; Patro P; Tomelleri A; Campochiaro C; Agarwal V; Sharma A
    Autoimmun Rev; 2023 Mar; 22(3):103275. PubMed ID: 36652977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective cohort study to assess PET-CT findings and clinical outcomes in Takayasu arteritis: does 18F-fluorodeoxyglucose uptake in arteries predict relapses?
    Janes ALF; Castro MF; Arraes AED; Savioli B; Sato EI; de Souza AWS
    Rheumatol Int; 2020 Jul; 40(7):1123-1131. PubMed ID: 32200427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India.
    Goel R; Kumar TS; Danda D; Joseph G; Jeyaseelan V; Surin AK; Bacon P
    J Rheumatol; 2014 Jun; 41(6):1183-9. PubMed ID: 24786922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab in Takayasu arteritis: a safe alternative?
    Karageorgaki ZT; Mavragani CP; Papathanasiou MA; Skopouli FN
    Clin Rheumatol; 2007 Jun; 26(6):984-7. PubMed ID: 16633710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Cooper LT; Matteson EL; Warrington KJ
    Mayo Clin Proc; 2013 Aug; 88(8):822-30. PubMed ID: 23849994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Persistence of Disease-Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil.
    Acurcio FA; Machado MA; Moura CS; Ferre F; Guerra AA; Andrade EI; Cherchiglia ML; Rahme E
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1489-96. PubMed ID: 26814681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
    Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
    Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they?
    Kermani TA; Crowson CS; Muratore F; Schmidt J; Matteson EL; Warrington KJ
    Semin Arthritis Rheum; 2015 Jun; 44(6):724-8. PubMed ID: 25712813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
    Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
    Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.